<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78810</article-id><article-id pub-id-type="doi">10.7554/eLife.78810</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Covalent disruptor of YAP-TEAD association suppresses defective hippo signaling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-274118"><name><surname>Fan</surname><given-names>Mengyang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-276311"><name><surname>Lu</surname><given-names>Wenchao</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1175-365X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276312"><name><surname>Che</surname><given-names>Jianwei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-116027"><name><surname>Kwiatkowski</surname><given-names>Nicholas P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276313"><name><surname>Gao</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-83474"><name><surname>Seo</surname><given-names>Hyuk-Soo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77301"><name><surname>Ficarro</surname><given-names>Scott B</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127093"><name><surname>Gokhale</surname><given-names>Prafulla C</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276314"><name><surname>Liu</surname><given-names>Yao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-276315"><name><surname>Geffken</surname><given-names>Ezekiel A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276316"><name><surname>Lakhani</surname><given-names>Jimit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276317"><name><surname>Song</surname><given-names>Kijun</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6037-9345</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276318"><name><surname>Kuljanin</surname><given-names>Miljan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276319"><name><surname>Ji</surname><given-names>Wenzhi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276320"><name><surname>Jiang</surname><given-names>Jie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3795-672X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276321"><name><surname>He</surname><given-names>Zhixiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276322"><name><surname>Tse</surname><given-names>Jason</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276323"><name><surname>Boghossian</surname><given-names>Andrew S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7008-8138</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276324"><name><surname>Rees</surname><given-names>Matthew G</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276325"><name><surname>Ronan</surname><given-names>Melissa M</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276326"><name><surname>Roth</surname><given-names>Jennifer A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276327"><name><surname>Mancias</surname><given-names>Joseph D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77304"><name><surname>Marto</surname><given-names>Jarrod A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-83475"><name><surname>Dhe-Paganon</surname><given-names>Sirano</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-276328"><name><surname>Zhang</surname><given-names>Tinghu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" corresp="yes" id="author-267719"><name><surname>Gray</surname><given-names>Nathanael S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5354-7403</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf7"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cancer Biology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Chemical and Systems Biology</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Blais Proteomics Center</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Experimental Therapeutics Core</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Radiation Oncology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Broad Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">The Blais Proteomics Center</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1156"><name><surname>Pan</surname><given-names>Duojia</given-names></name><role>Reviewing editor</role><aff><institution>UT Southwestern Medical Center and HHMI</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ztinghu8@stanford.edu</email> (TZ);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>nsgray01@stanford.edu</email> (NG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>10</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78810</elocation-id><history><date date-type="received"><day>21</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Fan et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Fan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78810-v1.pdf"/><abstract><p>The transcription factor TEAD, together with its coactivator YAP/TAZ, is a key transcriptional modulator of the Hippo pathway. Activation of TEAD transcription by YAP has been implicated in a number of malignancies, and this complex represents a promising target for drug discovery. However, both YAP and its extensive binding interfaces to TEAD have been difficult to address using small molecules, mainly due to a lack of druggable pockets. TEAD is post-translationally modified by palmitoylation that targets a conserved cysteine at a central pocket, which provides an opportunity to develop cysteine-directed covalent small molecules for TEAD inhibition. Here, we employed covalent fragment screening approach followed by structure-based design to develop an irreversible TEAD inhibitor MYF-03-69. Using a range of <italic>in vitro</italic> and cell-based assays we demonstrated that through a covalent binding with TEAD palmitate pocket, MYF-03-69 disrupts YAP-TEAD association, suppresses TEAD transcriptional activity and inhibits cell growth of Hippo signaling defective malignant pleural mesothelioma (MPM). Further, a cell viability screening with a panel of 903 cancer cell lines indicated a high correlation between TEAD-YAP dependency and the sensitivity to MYF-03-69. Transcription profiling identified the upregulation of proapoptotic <italic>BMF</italic> gene in cancer cells that are sensitive to TEAD inhibition. Further optimization of MYF-03-69 led to an <italic>in vivo</italic> compatible compound MYF-03-176, which shows strong antitumor efficacy in MPM mouse xenograft model via oral administration. Taken together, we disclosed a story of the development of covalent TEAD inhibitors and its high therapeutic potential for clinic treatment for the cancers that are driven by TEAD-YAP alteration.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><funding-statement>The Gray lab has sponsored research agreement for TEAD inhibitor project with Epiphanes. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Mengyang Fan, is one of the inventors on TEAD inhibitor patents (WO2020081572A1).</p></fn><fn fn-type="conflict" id="conf3"><p>Jianwei Che, is a consultant to Soltego, Jengu, Allorion, EoCys, and equity holder for Soltego, Allorion, EoCys, and M3 bioinformatics &amp; technology Inc..</p></fn><fn fn-type="conflict" id="conf4"><p>Yang Gao, is one of the inventors on TEAD inhibitor patents (WO2020081572A1).</p></fn><fn fn-type="conflict" id="conf5"><p>Yao Liu, is one of the inventors on TEAD inhibitor patents (WO2020081572A1).</p></fn><fn fn-type="conflict" id="conf6"><p>Tinghu Zhang, is a consultant and equity holder of EoCys and is one of the inventors on TEAD inhibitor patents (WO2020081572A1)..</p></fn><fn fn-type="conflict" id="conf7"><p>Nathanael S Gray, is a founder, science advisory board (SAB) member and equity holder in Syros, Jengu, C4, B2S, Allorion, Inception, GSK, Larkspur (board member) and Soltego (board member). The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Interline, Springworks and Sanofi. TEAD inhibitors developed in this manuscript are licensed to a start-up ( Lighthorse) where Gray has a financial interest. N.S.G. is one of the inventors on TEAD inhibitor patents (WO2020081572A1)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animals acclimated for at least 5 days before initiation of the study. All in vivo studies were conducted at Dana-Farber Cancer Institute with the approval of the Institutional Animal Care and Use Committee in an AAALAC accredited vivarium.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Diffraction data have been deposited in PDB under the accession code 7LI5.RNA sequencing data have been deposited in BioSample database under accession codes SAMN19288936, SAMN19288937, SAMN19288938, SAMN19288939, SAMN19288940, SAMN19288941, SAMN19288942, SAMN19288943, SAMN19288944, SAMN19288945 and SAMN19288946.All datasets generated or analyzed during this study have been deposited in Dryad.Uncropped gels or blots image of Figure 1e, 2e, 3a, 3b, 4d and their related figure supplement 3, 4, 7 were provided in the zipped folder &quot;Source data files&quot;.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Fan M</collab></person-group><year iso-8601-date="2022">2022</year><source>Supplementary dataset 1: Proteome-wide selectivity profile of MYF-03-69 on cysteines labeling using SLC-ABPP approach</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.rxwdbrvbn">https://dx.doi.org/10.5061/dryad.rxwdbrvbn</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.rxwdbrvbn</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Fan M</collab></person-group><year iso-8601-date="2022">2022</year><source>Supplementary Dataset 2. List of differentially expressed genes under MYF-03-69 treatments</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.sn02v6x6g">https://dx.doi.org/10.5061/dryad.sn02v6x6g</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.sn02v6x6g</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Fan M</collab></person-group><year iso-8601-date="2022">2022</year><source>Supplementary Dataset 3. Area under the curve (AUC) data of PRISM cell viability screen and corresponding CERES scores of YAP1 and TEADs</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.3r2280gjk">https://dx.doi.org/10.5061/dryad.3r2280gjk</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.3r2280gjk</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Fan M</collab></person-group><year iso-8601-date="2022">2022</year><source>Supplementary Dataset 4. Correlation analysis of MYF-03-69 PRISM sensitivity profile and gene DepMap dependency scores</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.kh189327w">https://dx.doi.org/10.5061/dryad.kh189327w</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.kh189327w</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-78810-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>